• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Is antiperspirant considered an OTC drug in the USA, and what does that mean for private label?

In the U.S., a deodorant intended only to control odor is a cosmetic; an antiperspirant intended to reduce sweating is a drug. A product with both uses may be both. Confirm the applicable product pathway, manufacturing and labeler roles, documentation and labeling requirements before planning a private-label launch.

US buyer view Launch planning Published: January 27, 2026
Chat on WhatsApp
Best for
Brand owners, distributors, and private label buyers
Core intent
Clarify the buyer question, product requirements, and next steps for the target market

Quick Answer (for busy buyers)

Applicable requirements and regulatory responsibilities depend on product classification and target market. Confirm the responsible parties and any filing or update obligations for your specific project.

  • First distinguish a deodorant cosmetic from an antiperspirant drug. In the U.S., a product intended only to deodorize is a cosmetic, while an antiperspirant intended to reduce sweating is a drug. A product with both uses may be both a cosmetic and a drug.
  • Before agreeing a private-label launch, identify the product’s regulatory pathway, the manufacturing and labeler roles, and the applicable registration, listing, labeling and manufacturing requirements with qualified U.S. regulatory support. Review the formula, actives, strengths and claims for the applicable pathway; labeling, including any required Drug Facts, directions and warnings, should be reviewed for applicable requirements.
  • Allocate responsibilities based on the actual product pathway and each party’s role. Do not assume that a general cosmetics responsible-person or product-listing process is sufficient for an antiperspirant drug.
  • Before requesting development or sampling, confirm whether the proposed manufacturing site and project arrangements are suitable for the intended U.S. antiperspirant pathway. General cosmetic manufacturing experience alone does not establish suitability for an OTC drug project.
  • MOQ is product/packaging dependent; for a market test, many brands start around 3,000-5,000 units per SKU, then scale.
  • We can help with concept positioning, product architecture, insert/price list drafts, and full VI + packaging sourcing.
  • Do not use a general cosmetics production timeline as a U.S. antiperspirant launch commitment. Confirm the product pathway, manufacturing site suitability, required documentation and testing, labeling reviewed for applicable requirements, and component readiness before agreeing a project-specific schedule.
  • We can also arrange third-party testing and track reports, plus provide logistics/shipping support.
Buyer outcome
Use the answer to clarify requirements, compare options, and prepare project questions.
Before requesting a quote
Confirm the target market, product type, packaging requirements, and unresolved details.
⚠️
This page is a practical buyer guide. For regulatory topics, verify current requirements with the relevant authorities and qualified advisers for your product and target market.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).